monoclonal antibody Igyxos/Selexis

N/A

Report date: 2025/03/20 15:30:20

Base Information

Drug Namemonoclonal antibody Igyxos/Selexis
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypogonadismInfertility, FemaleInfertility, Male
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIgyxos SA
China Registration ClassN/A

Develop Information

Active CompaniesIgyxos SASelexis SA
Inactive CompaniesN/A
Active IndicationsHypogonadismInfertility, FemaleInfertility, Male
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A